Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Syntel, Inc. (SYNT) Going to Burn These Hedge Funds?

Page 1 of 2

What’s a smart  Syntel, Inc. (NASDAQ:SYNT) investor to do?

To the average investor, there are a multitude of gauges shareholders can use to watch publicly traded companies. A pair of the most innovative are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the top investment managers can outperform the broader indices by a solid margin (see just how much).

Equally as crucial, bullish insider trading sentiment is another way to look at the investments you’re interested in. Just as you’d expect, there are a variety of stimuli for an executive to drop shares of his or her company, but just one, very clear reason why they would buy. Several empirical studies have demonstrated the impressive potential of this tactic if “monkeys” know where to look (learn more here).

Furthermore, we’re going to analyze the latest info about Syntel, Inc. (NASDAQ:SYNT).

Syntel, Inc. (NASDAQ:SYNT)

What have hedge funds been doing with Syntel, Inc. (NASDAQ:SYNT)?

In preparation for the third quarter, a total of 12 of the hedge funds we track were long in this stock, a change of 9% from the first quarter. With hedge funds’ capital changing hands, there exists a few notable hedge fund managers who were upping their holdings considerably.

According to our 13F database, Renaissance Technologies, managed by Jim Simons, holds the biggest position in Syntel, Inc. (NASDAQ:SYNT). Renaissance Technologies has a $29.4 million position in the stock, comprising 0.1% of its 13F portfolio. Sitting at the No. 2 spot is Royce & Associates, managed by Chuck Royce, which held a $20.9 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Some other hedge funds that are bullish include Martin Whitman’s Third Avenue Management, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital and Joel Greenblatt’s Gotham Asset Management.

As aggregate interest spiked, certain bigger names were breaking ground themselves. Renaissance Technologies, managed by Jim Simons, assembled the most valuable position in Syntel, Inc. (NASDAQ:SYNT). Renaissance Technologies had 29.4 million invested in the company at the end of the quarter. Chuck Royce’s Royce & Associates also made a $20.9 million investment in the stock during the quarter. The other funds with new positions in the stock are Martin Whitman’s Third Avenue Management, Peter Rathjens, Bruce Clarke and John Campbell’s Arrowstreet Capital, and Joel Greenblatt’s Gotham Asset Management.

How are insiders trading Syntel, Inc. (NASDAQ:SYNT)?

Insider buying is best served when the company we’re looking at has experienced transactions within the past half-year. Over the latest 180-day time period, Syntel, Inc. (NASDAQ:SYNT) has experienced zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also examine the relationship between both of these indicators in other stocks similar to Syntel, Inc. (NASDAQ:SYNT). These stocks are Rackspace Hosting, Inc. (NYSE:RAX), Gartner Inc (NYSE:IT), Acxiom Corporation (NASDAQ:ACXM), ServiceNow Inc (NYSE:NOW), and NCR Corporation (NYSE:NCR). This group of stocks are the members of the information technology services industry and their market caps match SYNT’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!